Wall Street analysts expect Encompass Health Corp (NYSE:EHC) to announce earnings of $0.82 per share for the current quarter, Zacks reports. Eight analysts have issued estimates for Encompass Health’s earnings, with estimates ranging from $0.78 to $0.96. Encompass Health posted earnings per share of $0.80 during the same quarter last year, which would indicate a positive year-over-year growth rate of 2.5%. The business is expected to report its next earnings results on Thursday, February 6th.
On average, analysts expect that Encompass Health will report full year earnings of $3.87 per share for the current fiscal year, with EPS estimates ranging from $3.83 to $4.00. For the next financial year, analysts forecast that the firm will report earnings of $3.72 per share, with EPS estimates ranging from $3.60 to $3.93. Zacks’ EPS averages are an average based on a survey of research analysts that follow Encompass Health.
Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Monday, October 28th. The company reported $0.93 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.89 by $0.04. The company had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.16 billion. Encompass Health had a net margin of 7.07% and a return on equity of 23.89%.
EHC has been the topic of a number of analyst reports. ValuEngine cut shares of Encompass Health from a “buy” rating to a “hold” rating in a research note on Wednesday, October 30th. Deutsche Bank assumed coverage on shares of Encompass Health in a research note on Tuesday, September 17th. They issued a “hold” rating and a $70.00 price target on the stock. Finally, Bank of America raised Encompass Health to a “buy” rating in a research report on Friday, September 6th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Encompass Health presently has a consensus rating of “Buy” and an average target price of $71.75.
Encompass Health stock traded up $0.63 during mid-day trading on Wednesday, reaching $71.18. The stock had a trading volume of 489,131 shares, compared to its average volume of 740,451. The company has a market capitalization of $6.97 billion, a price-to-earnings ratio of 19.61, a PEG ratio of 2.07 and a beta of 0.85. The company has a 50-day moving average price of $68.71 and a two-hundred day moving average price of $63.90. Encompass Health has a one year low of $56.74 and a one year high of $74.52. The company has a debt-to-equity ratio of 1.94, a current ratio of 0.97 and a quick ratio of 0.97.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a yield of 1.57%. The ex-dividend date of this dividend is Tuesday, December 31st. Encompass Health’s dividend payout ratio (DPR) is 30.85%.
Encompass Health Company Profile
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Recommended Story: Forex
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.